Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

TolerogenixX GmbH

TolerogenixX GmbH_logo
11
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Heidelberg, Stadt, Baden-Württemberg, Germany

Send a message

Anglais

TolerogenixX GmbH

Anglais

TolerogenixX was founded in 2016 by a group of physicians from the University of Heidelberg. The idea to develop an alternative to standard immunosuppression arose from the desire to no longer treat transplanted patients (Tx) and autoimmune patients (AI) with a broad, unspecific weakening of the natural defences of their body, but to eliminate the cause of the problem.

Vision

TolerogenixX will innovate immunosuppression with its newly developed MIC cell treatments.

...
See more

TolerogenixX was founded in 2016 by a group of physicians from the University of Heidelberg. The idea to develop an alternative to standard immunosuppression arose from the desire to no longer treat transplanted patients (Tx) and autoimmune patients (AI) with a broad, unspecific weakening of the natural defences of their body, but to eliminate the cause of the problem.

Vision

TolerogenixX will innovate immunosuppression with its newly developed MIC cell treatments.

MIC cell treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Tx and AI patients.

By 2025, TolerogenixX will have treated more than 25,000 patients and reached unicorn status with 3.5 billion € of sales.

Identity

TolerogenixX is a highly innovative start-up company that will contribute to the launch of a new era in medical treatment, the era of cell and gene therapy. We are an interdisciplinary team consisting of competent and highly committed experts. It is our clear ambition to be an accountable partner for investors, scientists, the medical community and authorities. We efficiently transform budget into values and facts. We have a clear vision and strategy and are committed to implementing them. We are highly visible and well regarded.

 

  • .

 

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With 892.5 M€ in investment volume across three funds and an international network of partners, HTGF has already helped forge more than 530 startups since 2005. Its team of experienced investment managers and startup experts help guide the development of young companies. We focus on high-tech startups in software, media, internet, hardware, automation, health care, chemistry and life sciences.
15 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members